| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 09/30/2009 | CN101543500A Dhea composition and method |
| 09/30/2009 | CN100544726C DHEA composition and method |
| 09/29/2009 | US7595399 Tyrosine derivatives |
| 09/29/2009 | US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 09/29/2009 | US7595319 Compounds having selective inhibiting effect at GSK3 |
| 09/29/2009 | CA2434009C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 09/29/2009 | CA2390295C A method for chemoprevention of prostate cancer |
| 09/29/2009 | CA2274758C Stable glassy state powder formulations |
| 09/29/2009 | CA1341598C Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex |
| 09/24/2009 | WO2009115503A1 Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
| 09/24/2009 | WO2009083268A3 17-(1'-propenyl)-17-3'-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative |
| 09/24/2009 | US20090239839 Receptor antagonist |
| 09/24/2009 | US20090239805 Human 3 relaxin |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239295 Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use |
| 09/24/2009 | CA2718744A1 Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
| 09/23/2009 | EP2103602A1 Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
| 09/23/2009 | EP2103598A1 Fluorinated cycloalkyl-derived benzoylguanidine, method for producing same, use of same as medicine and medicine containing same |
| 09/23/2009 | EP2102170A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/23/2009 | EP1651213B1 Use of angiotensin ii receptor antagonists, especially telmisartan, in order to increase insulin sensitivity |
| 09/23/2009 | EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/23/2009 | EP1420827B1 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 09/23/2009 | EP1377288B1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and use |
| 09/23/2009 | CN101537182A Combination comprising an HMG CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |
| 09/23/2009 | CN101537018A Preparation method and clinical application of medicament for treating androgenetic alopecia |
| 09/23/2009 | CN101536993A Vitamin D3 microcapsule and preparation method thereof |
| 09/23/2009 | CN100542538C Matrix film tablet with controlled release a natural mixture of conjugated estrogens |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592329 containing an anti-inflammatory and anti-allergic compound of the androstane series |
| 09/22/2009 | US7592323 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 09/22/2009 | CA2523960C Diaminopyrroloquinazolines compounds as protein tyrosine phosphatase inhibitors |
| 09/22/2009 | CA2432534C Gel composition and trans-scrotal application of a composition for the treatment of hypogonadism |
| 09/22/2009 | CA2402121C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 09/17/2009 | WO2009085880A3 C-21 thioethers as glucocorticoid receptor agonists |
| 09/17/2009 | US20090234070 Water-Soluble Polymer Alkanals |
| 09/17/2009 | US20090233995 Use of drug combinations for treating insulin resistance |
| 09/17/2009 | US20090233813 Condensed Heterocyclic Pyrazole Derivatives as Kinase Inhibitors |
| 09/17/2009 | US20090233363 Dedifferentiated, Programmable Stem Cells of Monocytic Origin, and Their Production and Use |
| 09/17/2009 | DE102007063495A1 19-Nor-Steroidderivate mit einer 15α,16α-Methylengruppe und einem gesättigten 17,17-Spirolactonring, deren Verwendung sowie diese Derivate enthaltende Arzneimittel 19-nor-steroid derivatives with a 15α, 16α-methyl group and a saturated 17,17-spirolactone, the use of these derivatives and pharmaceutical compositions containing them |
| 09/16/2009 | EP2100901A1 Modified Insulin and conjugates thereof |
| 09/16/2009 | EP2099814A1 Substituted estratrien derivatives as 17beta hsd inhibitors |
| 09/16/2009 | EP1438583B1 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 09/16/2009 | EP1283834B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 09/16/2009 | CN101530489A Chinese medicine composition used for treating non-active stage infiltrative exophthalmos of thyroid-associated ophthalmopathy and preparation method thereof |
| 09/16/2009 | CN100540566C Analogues of GLP-1 |
| 09/16/2009 | CN100540048C Angiogenesis inducer |
| 09/15/2009 | US7589091 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 09/15/2009 | US7589082 Making a slow release estradiol formulation by exposing particles of estradiol and cholesterol to a low relative humidity, then a solvent-saturated atmosphere of acetone and water, drying and recovering; avoids undesirable hormone imbalances; can be injected monthly; low estradiol dissolution rate (EDR) |
| 09/15/2009 | CA2429220C Gaba enhancers in the treatment of diseases relating to reduced neurosteroid activity |
| 09/15/2009 | CA2372560C Cyanopyrroles for binding the progesterone receptor |
| 09/11/2009 | WO2009110495A1 Promoter for secretion of insulin-like growth factor-1, and food or beverage containing the same |
| 09/11/2009 | WO2009083267A3 Steroid-17,17-lactol derivative, use thereof, and medicament containing said derivative |
| 09/11/2009 | WO2009050197A3 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 09/10/2009 | US20090227565 Biphenyl Vasopressin Agonists |
| 09/10/2009 | US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/10/2009 | US20090226540 Methods and Compositions For Treating Feline Hyperthyroidism |
| 09/10/2009 | US20090226403 Olfactory and pheromones G-protein coupled receptors |
| 09/10/2009 | US20090226368 Androgen-Receptor (AR) Ligands for Use in the Treatment and Diagnosis of AR-Related Pathologies |
| 09/09/2009 | EP2098513A1 Tricyclic compound and pharmaceutical use thereof |
| 09/09/2009 | EP2098507A1 Cyclic amine compound |
| 09/09/2009 | EP2098247A2 Prevention and treatment of androgen-deprivation induced loss of BMD or bone fractures |
| 09/09/2009 | EP2097420A1 Spiroketone acetyl-coa carboxylase inhibitors |
| 09/09/2009 | EP2097385A1 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands |
| 09/09/2009 | EP1638963B1 N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors |
| 09/09/2009 | EP1532109B1 Pyrrolidine derivatives as oxytocin antagonists |
| 09/09/2009 | EP1515947B1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 09/09/2009 | EP1446733B1 Glycosylphosphatidylinositol containing polypeptides |
| 09/09/2009 | CN101525359A Hydroxypropyl isoquercitrin, hydroxypropyl isoquercitrin derivative and preparation method thereof |
| 09/09/2009 | CN101524530A The treatment of diabetes |
| 09/09/2009 | CN101524409A Chinese medicine composition used for improving the level of serum testosterone and preparing method thereof |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/09/2009 | CN100537520C N-bridged selective androgen receptor modulators and methods of use thereof |
| 09/09/2009 | CN100536922C Polymeric delivery formulations of leuprolide with improved efficacy |
| 09/08/2009 | US7585977 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585853 Compounds having selective inhibiting effect at GSK3 |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | CA2360220C Oxadiazole compounds and compositions for delivering active agents |
| 09/08/2009 | CA2342739C Azetidine derivatives, preparation and medicines containing them |
| 09/08/2009 | CA2284750C Steroid sulfamates, method for the production and use thereof |
| 09/08/2009 | CA2253673C 21-substituted progesterone derivatives as new antiprogestational agents |
| 09/06/2009 | CA2713254A1 Use of ulipristal for treating uterine fibroids |
| 09/03/2009 | WO2009082437A3 Selective androgen receptor modulators (sarms) and uses thereof |
| 09/03/2009 | US20090221695 Chroman Derivatives as Estrogenic Compounds |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221543 New corticosteroids |
| 09/03/2009 | DE19521720B4 Insulinanalogonformulierungen Insulin analog formulations |
| 09/02/2009 | EP1893630B1 Steroids having a mixed androgenic and progestagenic profile |
| 09/02/2009 | EP1478233A4 Method for administering glp-1 molecules |
| 09/02/2009 | EP1470137B1 Edg receptor agonists |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1282617B1 Hydantoin derivatives with affinity for somatostatin receptors |
| 09/02/2009 | EP1276483B1 Compositions and methods for treating amyloidosis using sulphonate derivatives |
| 09/02/2009 | CN101518650A Combination of a DPP IV inhibitor and a cardiovascular compound |
| 09/02/2009 | CN100534997C C-aryl glucoside SGLT2 inhibitors and method |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/02/2009 | CN100534419C Colloidal suspension of nanoparticles based on am amphiphilic copolymer |
| 09/01/2009 | US7582658 Bicyclic compound |
| 09/01/2009 | US7582653 Mercaptophenyl naphthyl methane compounds and synthesis thereof |